Filing Details
- Accession Number:
- 0000950142-14-001162
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-28 16:55:26
- Reporting Period:
- 2014-05-23
- Filing Date:
- 2014-05-28
- Accepted Time:
- 2014-05-28 16:55:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1261249 | Agile Therapeutics Inc | AGRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1172252 | N Andrew Schiff | 888 Seventh Avenue 30Th Fl New York NY 10106 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-23 | 1,333,333 | $6.00 | 2,171,831 | No | 4 | P | Indirect | By Aisling Capital III, LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Aisling Capital III, LP |
Footnotes
- The reportable securities are owned directly by Aisling Capital III, LP ("Aisling"), and held indirectly by Aisling Capital Partners III, LP ("Aisling GP"), as general partner of Aisling, Aisling Capital Partners III LLC ("Aisling Partners"), as general partner of Aisling GP, and voting decisions are made by an investment committee of Aisling, which currently consists of six members, including Dr. Schiff. The investment committee shares voting and dispositive power over the shares held directly by Aisling GP. Dr. Schiff disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
Billionaire Hedge Funds
